Vijay K Chopra
9PUBLICATIONS
75CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 30, 2025
Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management.Jabir Abdulakutty, Atul Abhyankar, Sandeep Seth
|Apr 06, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.Adrian F Hernandez, Jacob A Udell, W Schuyler Jones
|Dec 09, 2022
Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry.Kanako Teramoto, Wan Ting Tay, Jasper Tromp
|Sep 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi
|Nov 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi
|Nov 08, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.David D Berg, Kieran F Docherty, Naveed Sattar
Pageof 2
Frequent Collaborators
3 joint publications
Stefan D Anker
3 joint publications
Martina Brueckmann
3 joint publications
Piotr Ponikowski
3 joint publications
Javed Butler
3 joint publications
James L Januzzi
2 joint publications
Gerasimos Filippatos
2 joint publications
Ileana L Piña
2 joint publications
Sanjay Kaul
2 joint publications
Michael Böhm
2 joint publications
Morten Schou
